Oral Beta-blocker in Problematic Infantile Hemangioma
Summary:. One of the most common benign vascular endothelial tumors is infantile hemangioma. These lesions are commonly found in the head and neck, and sometimes it is a challenge to decide the method of treatment if the lesions are problematic hemangiomas, interfering with function or aesthetic app...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2021-05-01
|
| Series: | Plastic and Reconstructive Surgery, Global Open |
| Online Access: | http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000003581 |
| _version_ | 1819103242646192128 |
|---|---|
| author | Rashed N. AlHasan, MB, BCh, BAO Lamees Arabiyat, MD, JBPRS, MCs Hamad M. Ammar, MBBCH, JBPRS Nayef A. Louri, MD, ADPS |
| author_facet | Rashed N. AlHasan, MB, BCh, BAO Lamees Arabiyat, MD, JBPRS, MCs Hamad M. Ammar, MBBCH, JBPRS Nayef A. Louri, MD, ADPS |
| author_sort | Rashed N. AlHasan, MB, BCh, BAO |
| collection | DOAJ |
| description | Summary:. One of the most common benign vascular endothelial tumors is infantile hemangioma. These lesions are commonly found in the head and neck, and sometimes it is a challenge to decide the method of treatment if the lesions are problematic hemangiomas, interfering with function or aesthetic appearance. This study reports a case of girl aged 3 years, 7 months, diagnosed with periorbital infantile hemangioma that was successfully treated with oral propranolol in specific doses and gradual tapering off dose. The patient had marked involution of the lesion with no significant side effects after starting her treatment at the age of 4 months, for a total of 13 months with no reported rebound growth after almost 2 years since the termination of treatment. Oral beta-blockers can be used safely in treatment of problematic infantile hemangioma as a single modality, without any surgical intervention. |
| first_indexed | 2024-12-22T01:47:21Z |
| format | Article |
| id | doaj.art-eccb9562d45b4349b0eee694cf5e9f0a |
| institution | Directory Open Access Journal |
| issn | 2169-7574 |
| language | English |
| last_indexed | 2024-12-22T01:47:21Z |
| publishDate | 2021-05-01 |
| publisher | Wolters Kluwer |
| record_format | Article |
| series | Plastic and Reconstructive Surgery, Global Open |
| spelling | doaj.art-eccb9562d45b4349b0eee694cf5e9f0a2022-12-21T18:43:01ZengWolters KluwerPlastic and Reconstructive Surgery, Global Open2169-75742021-05-0195e358110.1097/GOX.0000000000003581202105000-00020Oral Beta-blocker in Problematic Infantile HemangiomaRashed N. AlHasan, MB, BCh, BAO0Lamees Arabiyat, MD, JBPRS, MCs1Hamad M. Ammar, MBBCH, JBPRS2Nayef A. Louri, MD, ADPS3From the * Department of Plastic Surgery & Burns, Bahrain Defense Force Royal Medical Services, Bahrain† Department of Plastic Reconstructive & Burns, Jordanian Royal Medical Services, Jordan‡ Department of Plastic Surgery & Burns, Bahrain Defense Force Royal Medical Services, Bahrain§ Department of Plastic Surgery & Burns, Bahrain Defense Force Royal Medical Services, Bahrain.Summary:. One of the most common benign vascular endothelial tumors is infantile hemangioma. These lesions are commonly found in the head and neck, and sometimes it is a challenge to decide the method of treatment if the lesions are problematic hemangiomas, interfering with function or aesthetic appearance. This study reports a case of girl aged 3 years, 7 months, diagnosed with periorbital infantile hemangioma that was successfully treated with oral propranolol in specific doses and gradual tapering off dose. The patient had marked involution of the lesion with no significant side effects after starting her treatment at the age of 4 months, for a total of 13 months with no reported rebound growth after almost 2 years since the termination of treatment. Oral beta-blockers can be used safely in treatment of problematic infantile hemangioma as a single modality, without any surgical intervention.http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000003581 |
| spellingShingle | Rashed N. AlHasan, MB, BCh, BAO Lamees Arabiyat, MD, JBPRS, MCs Hamad M. Ammar, MBBCH, JBPRS Nayef A. Louri, MD, ADPS Oral Beta-blocker in Problematic Infantile Hemangioma Plastic and Reconstructive Surgery, Global Open |
| title | Oral Beta-blocker in Problematic Infantile Hemangioma |
| title_full | Oral Beta-blocker in Problematic Infantile Hemangioma |
| title_fullStr | Oral Beta-blocker in Problematic Infantile Hemangioma |
| title_full_unstemmed | Oral Beta-blocker in Problematic Infantile Hemangioma |
| title_short | Oral Beta-blocker in Problematic Infantile Hemangioma |
| title_sort | oral beta blocker in problematic infantile hemangioma |
| url | http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000003581 |
| work_keys_str_mv | AT rashednalhasanmbbchbao oralbetablockerinproblematicinfantilehemangioma AT lameesarabiyatmdjbprsmcs oralbetablockerinproblematicinfantilehemangioma AT hamadmammarmbbchjbprs oralbetablockerinproblematicinfantilehemangioma AT nayefalourimdadps oralbetablockerinproblematicinfantilehemangioma |